Loxo Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Loxo Oncology and buy or sell other stocks, ETFs, and their options commission-free!About LOXO
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing.
CEOJacob S. van Naarden
CEOJacob S. van Naarden
Employees—
Employees—
HeadquartersStamford, Connecticut
HeadquartersStamford, Connecticut
Founded2013
Founded2013
Employees—
Employees—
LOXO Key Statistics
Market cap7.17B
Market cap7.17B
Price-Earnings ratio-112.57
Price-Earnings ratio-112.57
Dividend yield—
Dividend yield—
Average volume479.60K
Average volume479.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$234.93
52 Week high$234.93
52 Week low$103.50
52 Week low$103.50
Stock Snapshot
The current Loxo Oncology(LOXO) stock price is $234.73, with a market capitalization of 7.17B. The stock trades at a price-to-earnings (P/E) ratio of -112.57.
During the trading day, Loxo Oncology(LOXO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 479.6K.
Over the past 52 weeks, Loxo Oncology(LOXO) stock has traded between a high of $234.93 and a low of $103.50.
Over the past 52 weeks, Loxo Oncology(LOXO) stock has traded between a high of $234.93 and a low of $103.50.